Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Why Index Weight Matters discusses the real-world effects of weighting choices on benchmarks and portfolio behavior.
22,027 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Space companies can soar one day and stumble the next. This article breaks down why spacex (spcx) stock plunged, what...
An unexpected move by Etsy’s board member sparked questions about insider trading activity. This article breaks down ...
Many retirees crave more space, less traffic, and predictable bills. Lapeer, Michigan delivers on all fronts by blend...
Dig into the drivers behind PAAS earnings and what they reveal about American silver mining. This guide explains how ...
Cameco stock sliding below $120 has investors weighing risk and opportunity. This guide breaks down the uranium outlo...
Struggling to manage money without breaking the bank? Affordable financial planning software options exist that can a...
New rental vacancy data shows rents cooling and inflation easing, signaling potential relief for mortgage rates in th...
A regional loan provider argues that trust and personal connection still drive loan success, releasing 2025 figures t...
The software sector is under pressure as AI-driven productivity bets collide with fears of cannibalization. ServiceNo...
The Pentagon’s fight with Anthropic has become a landmark test of how the U.S. will regulate powerful AI. Markets and...
A high-stakes clash between two top AI firms and the Pentagon exemplifies growing concerns about governance, safety, ...